A Study of FL115 Monotherapy in Unresectable or Metastatic Solid Tumors
Clinical trial NCT07131189 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07131189
- Sponsor
- Suzhou Forlong Biotechnology Co., Ltd
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-30
- Primary completion
- 2026-06-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.